JP2013078329A5 - - Google Patents

Download PDF

Info

Publication number
JP2013078329A5
JP2013078329A5 JP2012264713A JP2012264713A JP2013078329A5 JP 2013078329 A5 JP2013078329 A5 JP 2013078329A5 JP 2012264713 A JP2012264713 A JP 2012264713A JP 2012264713 A JP2012264713 A JP 2012264713A JP 2013078329 A5 JP2013078329 A5 JP 2013078329A5
Authority
JP
Japan
Prior art keywords
seq
dehalogenase
mutant dehalogenase
mutant
substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012264713A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013078329A (ja
JP5840117B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2013078329A publication Critical patent/JP2013078329A/ja
Publication of JP2013078329A5 publication Critical patent/JP2013078329A5/ja
Application granted granted Critical
Publication of JP5840117B2 publication Critical patent/JP5840117B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012264713A 2006-10-30 2012-12-03 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質 Active JP5840117B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85523706P 2006-10-30 2006-10-30
US60/855,237 2006-10-30
US93020107P 2007-05-15 2007-05-15
US60/930,201 2007-05-15

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2009534717A Division JP5680302B2 (ja) 2006-10-30 2007-10-30 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質

Publications (3)

Publication Number Publication Date
JP2013078329A JP2013078329A (ja) 2013-05-02
JP2013078329A5 true JP2013078329A5 (cg-RX-API-DMAC7.html) 2013-10-03
JP5840117B2 JP5840117B2 (ja) 2016-01-06

Family

ID=39344927

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009534717A Active JP5680302B2 (ja) 2006-10-30 2007-10-30 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質
JP2012264713A Active JP5840117B2 (ja) 2006-10-30 2012-12-03 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009534717A Active JP5680302B2 (ja) 2006-10-30 2007-10-30 キネティクス及び機能発現が高められた突然変異形ヒドロラーゼ・タンパク質

Country Status (5)

Country Link
US (5) US8420367B2 (cg-RX-API-DMAC7.html)
EP (4) EP2374875B1 (cg-RX-API-DMAC7.html)
JP (2) JP5680302B2 (cg-RX-API-DMAC7.html)
CA (1) CA2667697A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008054821A2 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
KR20050109934A (ko) 2003-01-31 2005-11-22 프로메가 코포레이션 관능기의 단백질로의 공유 테더링
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
EP2374875B1 (en) 2006-10-30 2015-09-02 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and funcitional expression
CA2815381C (en) 2010-11-02 2019-03-19 Promega Corporation Coelenterazine derivatives and methods of using same
CN103443121B (zh) 2010-11-02 2016-04-20 普罗梅加公司 新型腔肠素底物及其使用方法
SG11201500799YA (en) 2012-07-31 2015-03-30 Basil M Hantash Hla g-modified cells and methods
US11072812B2 (en) 2013-03-15 2021-07-27 Promega Corporation Substrates for covalent tethering of proteins to functional groups or solid surfaces
US9790537B2 (en) 2014-01-29 2017-10-17 Promega Corporation Quinone-masked probes as labeling reagents for cell uptake measurements
EP3099691B1 (en) 2014-01-29 2019-11-20 Promega Corporation Pro-substrates for live cell applications
KR20190025362A (ko) * 2017-09-01 2019-03-11 삼성전자주식회사 할로산 데할로게나제 수퍼패밀리 단백질 변이체 및 그를 이용한 시료 중 불소 함유 화합물의 농도를 감소시키는 방법
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
WO2020175502A1 (ja) * 2019-02-27 2020-09-03 国立大学法人東京医科歯科大学 抗原結合タンパク質と蛍光タンパク質または蛍光標識されるタグタンパク質との融合タンパク質
CN110819612A (zh) * 2019-11-29 2020-02-21 天津科技大学 新型抗自切碱性蛋白酶的筛选
KR20230147105A (ko) 2021-01-28 2023-10-20 진콴텀 헬스케어 (쑤저우) 씨오., 엘티디. 리가제 융합 단백질 및 그 응용
JP7851558B2 (ja) * 2021-02-19 2026-04-27 国立研究開発法人産業技術総合研究所 標的タンパク質の生産方法
CN115322980B (zh) * 2021-05-11 2024-04-02 中国科学院化学研究所 酰胺水解酶突变体及其在手性环状化合物合成上的应用
EP4206674B1 (en) 2021-12-28 2025-10-22 Encodia, Inc. High-throughput serotyping and antibody profiling assays
WO2023215514A2 (en) 2022-05-04 2023-11-09 Promega Corporation Bioluminescence-triggered photocatalytic labeling
US20240132859A1 (en) * 2022-05-04 2024-04-25 Promega Corporation Modified dehalogenase with extended surface loop regions
JP2025516354A (ja) 2022-05-04 2025-05-27 プロメガ コーポレイション スプリット修飾デハロゲナーゼバリアント
EP4519290A1 (en) * 2022-05-04 2025-03-12 Promega Corporation Circularly permuted dehalogenase variants
KR20250031198A (ko) 2022-07-01 2025-03-06 진콴텀 헬스케어 (쑤저우) 씨오., 엘티디. 고정화된 엔도글리코시다아제 융합 단백질 및 이의 적용
CN121794397A (zh) * 2023-05-04 2026-04-03 普洛麦格公司 用于双模态标记的基于互补性的标签和报告基因
WO2025090949A1 (en) * 2023-10-27 2025-05-01 Trustees Of Tufts College Fluorogenic self-labeling enzyme compositions, systems, and kits
CN118165960B (zh) * 2024-03-25 2025-03-25 南京大学 一种内切β-1,4-葡聚糖酶突变体及其基因、载体和制备方法

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3131122A (en) 1961-04-14 1964-04-28 Boehringer Sohn Ingelheim Method of producing analgesia with n-substituted-4-phenyl-4-carbalkoxypiperidines
DE1229532B (de) 1961-04-14 1966-12-01 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer Piperidinderivate
US3420367A (en) 1967-05-25 1969-01-07 Du Pont Multiple container package
US4574079A (en) 1983-05-27 1986-03-04 Gavras Haralambos P Radiolabeled angiotensin converting enzyme inhibitors for radiolabeling mammalian organ sites
US4612302A (en) 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4684620A (en) 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4812409A (en) 1986-01-31 1989-03-14 Eastman Kodak Company Hydrolyzable fluorescent substrates and analytical determinations using same
US4853371A (en) 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4818807A (en) 1986-09-04 1989-04-04 Idemitsu Kosan Co., Ltd. Liquid-crystalline polymer
US4810636A (en) 1986-12-09 1989-03-07 Miles Inc. Chromogenic acridinone enzyme substrates
CS259396B1 (sk) 1987-05-06 1988-10-14 Jozef Luston l,2,2,6,6-PentametyI-4-(w-brĎmalkoxy)piperidíny a spásob ich přípravy
SE8900130L (sv) 1989-01-16 1990-07-17 Klaus Mosbach Konceptet att med hjaelp av molekylavtrycksmetoden framstaella konstgjorda antikroppar genom imprinting av t ex antigener samt att framstaella konstgjorda entzymer genom imprintning med transition state analoger
US5071469A (en) 1989-04-21 1991-12-10 E. I. Du Pont De Nemours And Company Herbicidal benzylsulfonamides
US5498694A (en) 1989-05-25 1996-03-12 La Jolla Cancer Research Foundation Peptides of the cytoplasmic domain of integrin
US5128247A (en) 1989-08-14 1992-07-07 Board Of Regents, The University Of Texas System Methods for isolation of nucleic acids from eukaryotic and prokaryotic sources
US5099020A (en) 1989-11-27 1992-03-24 Abbott Laboratories Barbiturate assay compositions and methods
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
US5576424A (en) 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
FR2700855B1 (fr) 1993-01-28 1995-03-03 Commissariat Energie Atomique Dosage immunométrique d'un antigène ou d'un haptène.
US6118047A (en) 1993-08-25 2000-09-12 Dekalb Genetic Corporation Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
US5372944A (en) 1993-10-14 1994-12-13 The Dow Chemical Company Method for conversion of halogenated hydrocarbons to halohydrins
US5523209A (en) 1994-03-14 1996-06-04 The Scripps Research Institute Methods for identifying inhibitors of integrin activation
US5503977A (en) 1994-04-22 1996-04-02 California Institute Of Technology Split ubiquitin protein sensor
JP3583489B2 (ja) 1994-12-22 2004-11-04 日清紡績株式会社 カルボジイミド誘導体
CH689633A5 (de) 1995-01-10 1999-07-30 Von Roll Umwelttechnik Ag Verfahren zur Kuehlung und Reinigung von Rauchgasen.
AU730969B2 (en) 1995-10-19 2001-03-22 University Of Washington Discrete-length polyethylene glycols
WO2000053744A2 (en) * 1999-03-09 2000-09-14 Diversa Corporation End selection in directed evolution
US6537776B1 (en) * 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US5786428A (en) 1996-03-27 1998-07-28 California Institute Of Technology Adsorbents for amino acid and peptide separation
US6255461B1 (en) 1996-04-05 2001-07-03 Klaus Mosbach Artificial antibodies to corticosteroids prepared by molecular imprinting
US6162931A (en) 1996-04-12 2000-12-19 Molecular Probes, Inc. Fluorinated xanthene derivatives
US5945526A (en) 1996-05-03 1999-08-31 Perkin-Elmer Corporation Energy transfer dyes with enhanced fluorescence
US6416733B1 (en) 1996-10-07 2002-07-09 Bristol-Myers Squibb Pharma Company Radiopharmaceuticals for imaging infection and inflammation
US5932421A (en) 1996-12-06 1999-08-03 The Scripps Research Institute Methods and cell lines for identification of regulators of integrin activation
EP0970224A1 (en) * 1997-02-13 2000-01-12 The Dow Chemical Company Recombinant haloaliphatic dehalogenases
US6333154B1 (en) 1997-12-04 2001-12-25 Institut Pasteur Bacterial multi-hybrid system and applications thereof
US20020042055A1 (en) 1999-12-23 2002-04-11 Affholter Joseph A. Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions
FR2804116B1 (fr) 2000-01-20 2002-08-23 Centre Nat Rech Scient Composes organosilicies, leur procede de preparation et leurs utilisations
AU2001238485A1 (en) 2000-02-18 2001-08-27 The Immune Response Corporation Methods and compositions for gene delivery
AU2001227280A1 (en) 2000-04-10 2001-10-23 The Scripps Research Institute Proteomic analysis using activity-based probe libraries
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
CA2424300A1 (en) 2000-10-02 2002-04-11 Molecular Probes, Inc. Reagents for labeling biomolecules having aldehyde or ketone moieties
KR20030051897A (ko) 2000-12-01 2003-06-25 다이버사 코포레이션 데할로게나제 활성을 가진 효소 및 이의 사용 방법
WO2002057411A2 (en) 2000-12-01 2002-07-25 Diversa Corporation Hydrolase enzymes and their use in kinetic resolution
US6800453B2 (en) 2001-01-23 2004-10-05 President And Fellows Of Harvard College Nucleic-acid programmable protein arrays
NZ540410A (en) 2001-04-10 2006-06-30 Ecole Polytech Methods using O6-alkylguanine-DNA alkyltransferases
AR039555A1 (es) 2001-11-08 2005-02-23 Upjohn Co Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano
EP1540008A4 (en) 2002-07-19 2006-04-12 Diversa Corp FLUORESCENT PROTEINS, NUCLEIC ACIDS ENCODING THEM, AND METHODS OF MAKING AND USING SAME
AU2003291151A1 (en) 2002-11-22 2004-06-18 Carnegie Mellon University Compositions and methods for the reversible capture of biomolecules
KR20050109934A (ko) * 2003-01-31 2005-11-22 프로메가 코포레이션 관능기의 단백질로의 공유 테더링
US7429472B2 (en) 2003-01-31 2008-09-30 Promega Corporation Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
US20050095651A1 (en) 2003-08-12 2005-05-05 The Regents Of The University Of California Photoswitchable method for the ordered attachment of proteins to surfaces
US8293503B2 (en) 2003-10-03 2012-10-23 Promega Corporation Vectors for directional cloning
US20070087400A1 (en) 2004-07-30 2007-04-19 Aldis Darzins Covalent tethering of functional groups to proteins and substrates therefor
US7425436B2 (en) 2004-07-30 2008-09-16 Promega Corporation Covalent tethering of functional groups to proteins and substrates therefor
EP1989548A2 (en) 2006-02-08 2008-11-12 Promega Corporation Compositions and methods for capturing and analyzing cross-linked biomolecules
EP2374875B1 (en) 2006-10-30 2015-09-02 Promega Corporation Mutant hydrolase proteins with enhanced kinetics and funcitional expression

Similar Documents

Publication Publication Date Title
JP2016523959A5 (cg-RX-API-DMAC7.html)
WO2009027063A3 (en) MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES
JP2009533033A5 (cg-RX-API-DMAC7.html)
JP2014193932A5 (cg-RX-API-DMAC7.html)
PL2089343T3 (pl) Reakcja chemiczna typu click do wytwarzania cząsteczek reporterowych
JP2016521250A5 (cg-RX-API-DMAC7.html)
JP2012115275A5 (cg-RX-API-DMAC7.html)
EP3792348A3 (en) Mutated rep encoding sequences for use in aav production
JP2013523179A5 (cg-RX-API-DMAC7.html)
JP2016525100A5 (cg-RX-API-DMAC7.html)
EA201001881A1 (ru) Пролинспецифичная протеаза из penicillium chrysogenum
MX2019012876A (es) Moleculas de union con dominios de fibronectina de tipo iii modificadas con cisteina.
RU2015103777A (ru) Кооперативные праймеры, зонды и их применения
CN101928767A (zh) 用于检测慢性粒细胞白血病bcr/abl融合基因的电化学dna生物传感器
JP2014533115A5 (cg-RX-API-DMAC7.html)
SG195302A1 (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same
JP2017060521A5 (cg-RX-API-DMAC7.html)
JP2012506237A5 (cg-RX-API-DMAC7.html)
DK2004814T3 (da) Gruppe af nye enantioselektive mikrobielle nitrilhydrataser med bred substratspecificitet
EP2554672A4 (en) NUCLEIC ACID STRUCTURE, METHOD FOR PRODUCING A COMPLEX AND SCREENING METHOD THEREFOR
WO2009090269A3 (en) Markers and diagnostic methods for metastasis
JP2016505514A5 (cg-RX-API-DMAC7.html)
JP2017160272A5 (cg-RX-API-DMAC7.html)
US10577396B2 (en) Tolan compound
JP2013055917A5 (cg-RX-API-DMAC7.html)